Literature DB >> 12763912

Na,K-ATPase in the regulation of epithelial cell structure.

Ayyappan K Rajasekaran1, Jegan Gopal, Sigrid A Rajasekaran.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12763912     DOI： 10.1111/j.1749-6632.2003.tb07276.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Ouabain-induced cochlear degeneration in rat.

Authors:  Yong Fu; Dalian Ding; Haiyan Jiang; Richard Salvi
Journal:  Neurotox Res       Date:  2012-04-03       Impact factor: 3.911

2.  Cyclophilin B interacts with sodium-potassium ATPase and is required for pump activity in proximal tubule cells of the kidney.

Authors:  Guillermo Suñé; Eduard Sarró; Marta Puigmulé; Joan López-Hellín; Madeleine Zufferey; Thomas Pertel; Jeremy Luban; Anna Meseguer
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

3.  S163 is critical for FXYD5 modulation of wound healing in airway epithelial cells.

Authors:  Timothy J Miller; Pamela B Davis
Journal:  Wound Repair Regen       Date:  2008 Nov-Dec       Impact factor: 3.617

4.  Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit.

Authors:  L J Inge; S A Rajasekaran; K Yoshimoto; P S Mischel; W McBride; E Landaw; A K Rajasekaran
Journal:  Histol Histopathol       Date:  2008-04       Impact factor: 2.303

5.  Na+/K+-ATPase α1 identified as an abundant protein in the blood-labyrinth barrier that plays an essential role in the barrier integrity.

Authors:  Yue Yang; Min Dai; Teresa M Wilson; Irina Omelchenko; John E Klimek; Phillip A Wilmarth; Larry L David; Alfred L Nuttall; Peter G Gillespie; Xiaorui Shi
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

6.  Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells.

Authors:  Maitham A Khajah; Princy M Mathew; Yunus A Luqmani
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

7.  FXYD proteins and sodium pump regulatory mechanisms.

Authors:  John Q Yap; Jaroslava Seflova; Ryan Sweazey; Pablo Artigas; Seth L Robia
Journal:  J Gen Physiol       Date:  2021-04-05       Impact factor: 4.086

8.  NKAIN2 functions as a novel tumor suppressor in prostate cancer.

Authors:  Xueying Mao; Fei Luo; Lara K Boyd; Bowei Zhou; Yanling Zhang; Elzbieta Stankiewicz; Jacek Marzec; Natasa Vasiljevic; Yongwei Yu; Ninghan Feng; Jia Xu; Attila Lorincz; Yong Jiang; Claude Chelala; Guoping Ren; Daniel M Berney; Shan-Chao Zhao; Yong-Jie Lu
Journal:  Oncotarget       Date:  2016-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.